Esther Rose

1.5k total citations
21 papers, 968 citations indexed

About

Esther Rose is a scholar working on Genetics, Oncology and Hematology. According to data from OpenAlex, Esther Rose has authored 21 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 9 papers in Oncology and 9 papers in Hematology. Recurrent topics in Esther Rose's work include Chronic Lymphocytic Leukemia Research (12 papers), Viral-associated cancers and disorders (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Esther Rose is often cited by papers focused on Chronic Lymphocytic Leukemia Research (12 papers), Viral-associated cancers and disorders (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Esther Rose collaborates with scholars based in United States, Germany and France. Esther Rose's co-authors include Louis M. Aledort, David Hakimian, D. Janson, Mark A. Hoffman, MS Tallman, Richard Alan Nelson, Ronald M. Bukowski, David L. Cutler, Craig Tendler and Daina Variakojis and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

Esther Rose

21 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esther Rose United States 14 624 357 335 253 251 21 968
Ferdinando Frigeri Italy 19 483 0.8× 422 1.2× 437 1.3× 339 1.3× 116 0.5× 60 1.2k
Niki Stavroyianni Greece 18 448 0.7× 177 0.5× 335 1.0× 222 0.9× 298 1.2× 59 863
James D’Rozario Australia 10 565 0.9× 259 0.7× 399 1.2× 163 0.6× 212 0.8× 25 872
Liana Gercheva Bulgaria 15 707 1.1× 765 2.1× 417 1.2× 194 0.8× 209 0.8× 46 1.3k
K Blake United States 7 267 0.4× 307 0.9× 501 1.5× 371 1.5× 192 0.8× 10 853
Gianluigi Castoldi Italy 19 278 0.4× 483 1.4× 180 0.5× 252 1.0× 330 1.3× 36 957
P Coser Italy 15 215 0.3× 490 1.4× 324 1.0× 339 1.3× 154 0.6× 38 914
K.F. Wong China 15 184 0.3× 282 0.8× 433 1.3× 359 1.4× 311 1.2× 56 875
Antonella Bardi Italy 21 624 1.0× 460 1.3× 515 1.5× 240 0.9× 309 1.2× 51 1.2k
Pierre Feugier France 18 782 1.3× 217 0.6× 715 2.1× 225 0.9× 413 1.6× 68 1.1k

Countries citing papers authored by Esther Rose

Since Specialization
Citations

This map shows the geographic impact of Esther Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Rose more than expected).

Fields of papers citing papers by Esther Rose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Rose. The network helps show where Esther Rose may publish in the future.

Co-authorship network of co-authors of Esther Rose

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Rose. A scholar is included among the top collaborators of Esther Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Rose. Esther Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trudeau, Jeremiah, et al.. (2020). Content validity of patient-reported outcomes for use in lower-risk myelodysplastic syndromes. Journal of Patient-Reported Outcomes. 4(1). 69–69. 6 indexed citations
2.
3.
4.
5.
Bukowski, Ronald M., et al.. (2002). Treating cancer with PEG Intron. Cancer. 95(2). 389–396. 118 indexed citations
6.
Talpaz, Moshe, Susan O’Brien, Esther Rose, et al.. (2001). Phase 1 study of polyethylene glycol formulation of interferon α-2B (Schering 54031) in Philadelphia chromosome–positive chronic myelogenous leukemia. Blood. 98(6). 1708–1713. 50 indexed citations
7.
Gilliland, D. Gary, Josef T. Prchal, J. McL. Bennett, et al.. (2000). Effect of recombinant human erythropoietin combined with granulocyte/ macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome. Blood. 95(4). 1175–1179. 71 indexed citations
8.
Hoffman, Mark A., et al.. (1997). Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up.. Journal of Clinical Oncology. 15(3). 1138–1142. 99 indexed citations
9.
10.
Saven, Alan, Wing K. Cheung, Isabel Smith Zubiaga, et al.. (1996). Pharmacokinetic study of oral and bolus intravenous 2-chlorodeoxyadenosine in patients with malignancy.. Journal of Clinical Oncology. 14(3). 978–983. 37 indexed citations
11.
Tallman, Martin S., et al.. (1995). Cladribine in the treatment of relapsed or refractory chronic lymphocytic leukemia.. Journal of Clinical Oncology. 13(4). 983–988. 53 indexed citations
12.
Rose, Esther, et al.. (1995). The use of r‐HuEpo in the treatment of anaemia related to myelodysplasia (MDS). British Journal of Haematology. 89(4). 831–837. 80 indexed citations
13.
Hakimian, David, et al.. (1994). Prospective evaluation of internal adenopathy in a cohort of 43 patients with hairy cell leukemia.. Journal of Clinical Oncology. 12(2). 268–272. 19 indexed citations
14.
Dimopoulos, Meletios Α., H. Kantarjian, D. Weber, et al.. (1994). Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine.. Journal of Clinical Oncology. 12(12). 2694–2698. 95 indexed citations
15.
16.
17.
Rose, Esther, Seth A. Rudnick, Robert Abels, et al.. (1991). Efficacy and safety of recombinant human erythropoietin r huepo in anemic patients with myelodysplastic syndromes. Leukemia Research. 15. 13. 6 indexed citations
18.
Rose, Esther & Louis M. Aledort. (1991). Nasal Spray Desmopressin (DDAVP) for Mild Hemophilia A and von Willebrand Disease. Annals of Internal Medicine. 114(7). 563–568. 91 indexed citations
19.
Gumaste, Vivek, et al.. (1990). Pancreatic Tuberculosis. Journal of Clinical Gastroenterology. 12(1). 74–77. 14 indexed citations
20.
Roboz, John, et al.. (1980). Mass spectrometric technique for the determination of N-phosphonoacetyl-l-aspartic acid in serum. Journal of Chromatography B Biomedical Sciences and Applications. 181(2). 195–205. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ferdinando Frigeri Breakdown of academic impact, for papers by Niki Stavroyianni Breakdown of academic impact, for papers by James D’Rozario Breakdown of academic impact, for papers by Liana Gercheva Breakdown of academic impact, for papers by K Blake Breakdown of academic impact, for papers by Gianluigi Castoldi Breakdown of academic impact, for papers by P Coser Breakdown of academic impact, for papers by K.F. Wong Breakdown of academic impact, for papers by Antonella Bardi Breakdown of academic impact, for papers by Pierre Feugier
Rankless by CCL
2026